ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 011

The Impact of Social Inequities on Presentation of Childhood-Onset Systemic Lupus Erythematosus (cSLE) at a Large Tertiary Center

Emily Beil1, Eyal Muscal2, Danielle Guffey2, Marietta Deguzman1 and Erin Peckham-Gregory2, 1Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 2Baylor College of Medicine, Houston, TX

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Access to care, Pediatric rheumatology, psychosocial factors, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, March 30, 2023

Title: Poster Breakout 1 - Lupus: Genetics, Epigenetics, & Social Determinants

Session Type: Breakout Session

Session Time: 5:10PM-5:40PM

Background/Purpose: Differences in prevalence rates of childhood-onset SLE (cSLE) among different racial/ethnic groups have been well described. Yet, the role of social determinants of health (SDoH) in severity of presentation is not well understood. We hypothesized that in an urban center with a large, diverse catchment area, SDoH may influence the severity of cSLE at initial diagnosis.

Methods: We completed an IRB-approved retrospective review of children diagnosed with cSLE between 1/1/18 – 5/31/22 at Texas Childrens Hospital in Houston, TX. Patients were excluded if diagnosis was made at an outside institution or diagnosed at 18 years. We abstracted demographics, clinical characteristics and SDoH data such as insurance status, social work consultation and access to PCP. Statistical analyses were performed using Stata v15.1 (StataCorp, College Station, TX, USA) and comparisons were made using ANOVA and Kruskal-Wallis tests.

Results: The mean age of the 136 patients who met inclusion criteria was 13.4 years + 3 SD. The majority of patients were female (n=112, 82.4%) and ~80% were Hispanic White (n=72, 52.9%) or Black (n=35, 25.7%). Fourteen (10.3%) patients were uninsured and 50% (n=68) had Medicaid or Childrens Health Insurance Program (CHIP). Half of the patients (n=68) were diagnosed during an inpatient admission with 49 (36%) on the floor and 19 (14%) in the ICU. The average SLEDAI was 12.5 + 7.1 SD with 48.5% (n=66) of patients presenting with SLEDAI 12 (severe disease). One third of patients preferred a language other than English (n=­­­44, 32.4%). Only 66% (n=91) of patients had a documented PCP. Social work was consulted in most patients as per section protocol (n=109, 80.1%); specific reasons listed in Table 1.

The distribution of race/ethnicity showed varied disease activity (SLEDAI and number of ACR criteria), CNS involvement and CYC therapy at levels that reached statistical significance (Table 2). Black and Biracial populations had higher SLEDAI scores at presentation (P =0.01). Non-Hispanic White patients were less likely to have a social work consult compared to the other race/ethnicities (P =0.01). CNS involvement was highest among Black children (P=0.004). CYC was most often used in Black and Biracial populations (P=0.003).

Several demographic and SDoH parameters influenced disease severity at levels that reached statistical significance, including insurance status, race/ethnicity, referral source, PCP availability, primary language, and transportation needs. When assessed by insurance status, uninsured patients were most likely to be diagnosed on an inpatient floor and those with Medicaid had the highest proportion of ICU admissions (P=0.034; Table 3). Uninsured patients and those on Medicaid had the highest percentage of social work consults (P =0.001).

Conclusion: In children drawn from a large urban catchment area, we observed an influence of race/ethnicity on disease severity, and also potential SDoH proxy measures (non-English primary language, insurance status and transportation barriers). Work is underway to target modifiable SDoH in our catchment area.

Supporting image 1Table 1. Select Patient and Social Characteristics (N&#3f136)

Supporting image 2Table 2. Summary Statistics by Race/Ethnicity

Supporting image 3Table 3. Summary Statistics by Insurance Status


Disclosures: E. Beil: None; E. Muscal: sobi, 1; D. Guffey: None; M. Deguzman: None; E. Peckham-Gregory: None.

To cite this abstract in AMA style:

Beil E, Muscal E, Guffey D, Deguzman M, Peckham-Gregory E. The Impact of Social Inequities on Presentation of Childhood-Onset Systemic Lupus Erythematosus (cSLE) at a Large Tertiary Center [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/the-impact-of-social-inequities-on-presentation-of-childhood-onset-systemic-lupus-erythematosus-csle-at-a-large-tertiary-center/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-social-inequities-on-presentation-of-childhood-onset-systemic-lupus-erythematosus-csle-at-a-large-tertiary-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology